The latest WHO classification of tumors of the CNS clearly states that GBMs will contain only IDH wild-type tumors and that all IDH-mutated diffuse astrocytic tumors are considered as a single type (astrocytoma, IDH-mutated) [3]. This evidence concerns the gene IDH2 and central nervous system neoplasm.